LifeStance Health Group (NASDAQ:LFST) Hits New 1-Year High – Here’s Why

LifeStance Health Group, Inc. (NASDAQ:LFST) shares hit a new 52-week high during trading on Wednesday. The company traded as high as $13.63 and last traded at $13.3650, with a volume of 3,127,325 shares trading hands. The stock had previously closed at $13.10.

Wall Street Analyst Weigh In

Several research firms have recently commented on LFST. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 5th. KeyCorp raised their price target on LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a report on Monday, October 5th. Barclays lifted their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, September 10th. Canaccord Genuity Group boosted their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, September 9th. Finally, JPMorgan Chase & Co. upped their target price on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $13.12.

LifeStance Health Group Trading Up 2.2%

The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The business’s 50-day moving average price is $12.43 and its two-hundred day moving average price is $9.25. The company has a market capitalization of $5.12 billion, a P/E ratio of 103.01 and a beta of 1.24.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%. The firm had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same period in the previous year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was up 26.1% on a year-over-year basis. As a group, analysts forecast that LifeStance Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Insider Activity at LifeStance Health Group

In related news, COO Lisa Miller sold 47,912 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $519,845.20. Following the completion of the sale, the chief operating officer directly owned 281,289 shares of the company’s stock, valued at approximately $3,051,985.65. This represents a 14.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CTO Vukasin Paunovich sold 44,394 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $481,674.90. Following the sale, the chief technology officer directly owned 247,446 shares of the company’s stock, valued at approximately $2,684,789.10. The trade was a 15.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 13,777,580 shares of company stock worth $146,433,781. 3.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On LifeStance Health Group

Several institutional investors have recently bought and sold shares of LFST. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of LifeStance Health Group by 57.3% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 36,500 shares of the company’s stock worth $439,000 after acquiring an additional 13,300 shares in the last quarter. Signaturefd LLC boosted its holdings in LifeStance Health Group by 35.6% during the third quarter. Signaturefd LLC now owns 5,357 shares of the company’s stock worth $64,000 after purchasing an additional 1,405 shares during the last quarter. Sterling Capital Management LLC boosted its holdings in LifeStance Health Group by 1,123.8% during the third quarter. Sterling Capital Management LLC now owns 8,236 shares of the company’s stock worth $99,000 after purchasing an additional 7,563 shares during the last quarter. Yousif Capital Management LLC grew its position in LifeStance Health Group by 19.3% in the third quarter. Yousif Capital Management LLC now owns 69,815 shares of the company’s stock valued at $840,000 after purchasing an additional 11,285 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in LifeStance Health Group by 55.1% in the third quarter. Nisa Investment Advisors LLC now owns 15,879 shares of the company’s stock valued at $191,000 after purchasing an additional 5,640 shares in the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns.